FDA.reportPublic FDA data

POLOXAMER 181

Substance profile for UNII 09Y8E6164A, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.

Substance Identity#

UNII
09Y8E6164A
Preferred term
POLOXAMER 181
Registry number
691397-13-4
Ingredient type
INGREDIENT SUBSTANCE
Molecular formula
Polymer substance not supported

Chemical And Database Identifiers#

RxCUI
1371947
PubChem
0
INN ID
0

Open Chemistry Sources#

Source, Identifier, Link table
SourceIdentifierLink
RxNorm1371947mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=1371947
FDA Substance Registration System09Y8E6164Aprecision.fda.gov/uniisearch/srs/unii/09Y8E6164A

DailyMed Socrata Ingredients#

DailyMed label, SPL version table
DailyMed labelSPL version
a8f7554c-eae7-44fb-ac66-a7d678bcb91a1
Omeprazole Delayed-Release Capsules These highlights do not include all the information needed to use Omeprazole Delayed-Release Capsules safely and effectively. See full prescribing information for Omeprazole Delayed-Release Capsules. Initial U.S. Approval: 01/21/20091
Drug Facts2
Drug Facts1
DOCU (DOCUSATE SODIUM) LIQUID [HI-TECH PHARMACAL CO., INC.]4
REPAGLINIDE TABLET [SUN PHARMACEUTICAL INDUSTRIES, INC.]3
DIOCTO (DOCUSATE SODIUM) LIQUID [THE HARVARD DRUG GROUP, LLC]2
DIOCTO (DOCUSATE SODIUM) SYRUP [RUGBY LABORATORIES]1
REPAGLINIDE (REPAGLINIDE) TABLET [AVKARE, INC.]1
REPAGLINIDE TABLET [AMERICAN HEALTH PACKAGING]1
REPAGLINIDE TABLET [AMERICAN HEALTH PACKAGING]1